Reflection
Before researching this topic, I understood breast cancer mostly as a disease of abnormal cell growth. My research helped me understand the science behind HER2-positive cancer specifically — how overexpression of the HER2 protein causes faster tumor growth and why targeted drugs are so important in treatment. I also learned that stage 4 breast cancer means the cancer has spread through the blood or lymph system to distant organs such as bone, lung, liver, or brain.[1]
The interview added something research alone cannot fully show. Medical sources explain symptoms, tests, drugs, and survival statistics, but a real person can explain fear, uncertainty, pain, hope, and the daily reality of living with treatment. That human perspective matters in healthcare because patients are not just diagnoses — they are people trying to function, cope, and maintain quality of life while facing a serious illness. NCI specifically notes that treatment for metastatic breast cancer often focuses not only on slowing the disease but also on improving quality of life — exactly what a patient's story makes visible.[1]
Connecting Science to Experience
Research shows that HER2-positive breast cancer grows aggressively due to overexpression of HER2 receptors that drive uncontrolled cell division.[2] The interview revealed how this rapid progression manifests outside the lab — a single self-exam lump escalating to a stage 4 diagnosis with liver metastases by the time of imaging. The biology of "aggressive" is not abstract; it is the difference between a clean mammogram one year and a metastatic PET scan the next.
The Cost of Survival
Targeted therapy with Herceptin (trastuzumab), and now newer agents like Enhertu plus pertuzumab approved by the FDA in December 2025,[7] have transformed HER2+ from one of the deadliest breast cancer subtypes into one of the most treatable. Yet "treatable" is not "untouched." Nine years of cardiac monitoring. A thyroid TSH of 121. Neuropathy. A hysterectomy chosen to remove the hormonal fuel of an ER+/PR+ tumor. The science worked — and it cost.
What Research Cannot Measure
No clinical trial reports the weight of wondering whether your daughters will inherit your disease. No survival curve captures the relief of an oncologist who lets you keep what defines you as a person. The interview filled in what data cannot — fear of the unknown, faith as a treatment in itself, and the quiet, ongoing question of every metastatic survivor: is it dormant, or is it sleeping?
Conclusion
Stage 4 HER2-positive breast cancer is a serious and life-changing disease, but research shows that treatment options have improved significantly because of HER2-targeted therapies. The disease begins in breast tissue, but once metastatic it can affect many body systems depending on where it spreads. Diagnosis depends on biopsy, imaging, and biomarker testing — including HER2 status by IHC or FISH.[2] Treatment often combines systemic therapy, targeted therapy, chemotherapy, symptom management, and sometimes radiation or surgery. Although metastatic breast cancer is not usually considered curable, it may be controlled for long periods, and some people live for years with treatment.[1]
This project also taught me that being a healthcare professional means more than understanding disease mechanisms. It means listening to patients, respecting their experiences, and recognizing how illness affects emotional health, family life, and everyday functioning. Learning both the medical facts and the human experience of disease can help me become a more empathetic and informed future healthcare worker.
"It's not a death sentence. Look to do the small important things every day."